Frontlight ResearchEarly access
Trial site
Maryland Oncology Hematology P.A.
- 12running trials
- 6closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Metastatic breast cancer3 trials
- Colorectal cancer2 trials
- Prostate cancer2 trials
- Childhood cancers1 trial
- Gastric and oesophageal cancer1 trial
- Melanoma1 trial
- Multiple myeloma1 trial
- Myeloproliferative neoplasms1 trial
- Neuroendocrine tumours1 trial
- Ovarian cancer1 trial
- Thyroid cancer1 trial
- and 1 more
- Phase
- Phase 311 trials
- Phase 25 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Recruiting7 trials
- Completed6 trials
- Active, not recruiting4 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Hoffmann-La Roche2 trials
- Incyte Corporation2 trials
- Pfizer2 trials
- US Oncology Research2 trials
- BioNTech SE1 trial
- and 9 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Enrolling by invitation
Active, not recruiting
Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer2 recruiting
- Gastric and oesophageal cancer1 recruiting
- Melanoma1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026